Scientific Communication Platform Development
Facilitating unified, consistent, and clear communication about a product to multiple external stakeholder groups.
The scientific communication platform provides a strategic foundation for a product’s medical communication plan and all initiatives generated from it by integrating scientific data, expected upcoming data, and treatment landscapes through coordinated scientific themes.
The burden of disease summary covering the following:
o Risk attribution
The medical unmet need in the disease management describes which currently available therapy does not adequately address the disease including:
o Where there are no approved molecules.
o Where there are few molecules in late phase clinical studies.
o Where existing molecules are compromised by substantial, demonstrated liability at efficacious dose.
o Where there is an identifiable subset of patients who are currently underserved.
Published real-world data incorporates financial costs of the disease for individuals, households, healthcare systems, and societies.
o Direct costs – the value of expenditures on prevention, diagnosis, and treatment, in-hospital and out-patient care, visits to physicians, and medications.
o Indirect costs – the value of labor and productivity losses, such as lost income and economic output due to illness-related absences from work, reduced productivity at work due to illness, or premature death.